What is necrotizing fascitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Necrotizing Fasciitis?

Necrotizing fasciitis is a life-threatening, rapidly spreading soft tissue infection characterized by necrosis of the fascia, subcutaneous tissue, and potentially deeper structures, requiring immediate surgical debridement to prevent death. 1

Definition and Pathophysiology

Necrotizing fasciitis is a severe invasive infection involving any or all layers of the soft-tissue compartment, from superficial dermis to deep fascia and muscle. 1 The infection spreads along fascial planes with secondary necrosis of overlying tissues, distinguishing it from simple cellulitis. 1, 2

Microbiology

The infection can be classified by bacterial etiology:

Monomicrobial infections (Type 2):

  • Group A Streptococcus (S. pyogenes) - most common, with mortality approaching 50-70% when associated with hypotension and organ failure 1
  • Staphylococcus aureus (including MRSA) 1
  • Vibrio vulnificus, Aeromonas hydrophila 1
  • Anaerobic streptococci (Peptostreptococcus species) 1

Polymicrobial infections (Type 1):

  • Average of 5 pathogens per wound, with up to 15 different organisms possible 1
  • Predominantly bowel or genitourinary flora (coliforms and anaerobes) 1
  • Associated with post-surgical infections, decubitus ulcers, perianal abscesses, injection drug use, or Bartholin gland infections 1

Clinical Presentation

Cardinal Diagnostic Features

The diagnosis is frequently missed initially (85-100% of cases), as it often resembles cellulitis. 2 Key distinguishing features include:

  • Severe pain disproportionate to physical findings - the most important early clinical indicator 1, 3
  • "Wooden-hard" feel of subcutaneous tissue extending beyond visible skin involvement 1
  • Systemic toxicity with altered mental status 1
  • Failure to respond to initial antibiotic therapy 1
  • Edema or tenderness extending beyond cutaneous erythema 1
  • Crepitus (gas in tissues) 1
  • Bullous lesions 1
  • Skin necrosis or ecchymoses 1

Laboratory Findings

  • Dramatically elevated CRP levels (5-fold higher than cellulitis) 3
  • Elevated serum urea and creatinine predict higher mortality 4
  • Low hemoglobin levels associated with worse outcomes 4
  • Poor white blood cell response, particularly in diabetic patients, correlates with higher mortality 4

Diagnosis

Clinical judgment remains the most important diagnostic element. 1 A high index of suspicion is paramount, as clinical scoring systems are more useful for excluding rather than confirming necrotizing infections. 1

Imaging

CT or MRI may show edema extending along fascial planes, but imaging should never delay surgical consultation and definitive treatment. 1 The sensitivity and specificity of these modalities remain poorly defined. 1

Definitive Diagnosis

The gold standard is direct surgical visualization showing: 1

  • Swollen, dull gray fascia with stringy necrosis
  • Thin, brownish exudate (not true pus)
  • Extensive undermining of tissues
  • Easy dissection of tissue planes with blunt instrument or gloved finger

When necrotizing fasciitis is suspected but not confirmed, exploratory incision in the area of maximum suspicion provides both diagnosis and treatment with minimal morbidity. 1

Treatment

Surgical Management (Primary Intervention)

Immediate aggressive surgical debridement is the cornerstone of treatment and must not be delayed. 1

  • Return to operating room every 24-36 hours for repeat debridement until no further necrosis is evident 1
  • Early amputation may be necessary in 27.8% of cases, with diabetes mellitus significantly increasing amputation risk 5, 4
  • Mean number of surgical interventions is approximately seven 5

Antimicrobial Therapy

For polymicrobial necrotizing fasciitis, empiric coverage must include agents effective against aerobes (including MRSA) and anaerobes: 1

Vancomycin, linezolid, or daptomycin PLUS one of:

  • Piperacillin-tazobactam
  • Carbapenem (imipenem-cilastatin, meropenem, or ertapenem)
  • Ceftriaxone plus metronidazole
  • Fluoroquinolone plus metronidazole

For Group A streptococcal infections: 1

  • Clindamycin PLUS penicillin
  • Clindamycin suppresses toxin and cytokine production and is superior to penicillin alone in animal models 1

Duration: Continue antibiotics until no further debridement is needed, clinical improvement occurs, and fever has been absent for 48-72 hours. 1

Supportive Care

  • Aggressive fluid resuscitation is mandatory, as wounds discharge copious tissue fluid 1
  • Intensive care management for sepsis and organ failure 1
  • Mean hospitalization is 32 days, including 8 days in ICU 5

Prognosis

  • Overall mortality remains 36% despite modern treatment 4
  • Mortality approaches 50-70% in streptococcal cases with hypotension and organ failure 1
  • Delay in diagnosis and treatment directly correlates with increased mortality 1, 2
  • Diabetes mellitus is a significant predictor of limb amputation 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Necrotizing fasciitis: classification, diagnosis, and management.

The journal of trauma and acute care surgery, 2012

Research

Necrotizing fasciitis: treatment concepts and clinical results.

European journal of trauma and emergency surgery : official publication of the European Trauma Society, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.